Position in ABBV
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$5,284,691
+$860,727 QoQ
Shares Held
21,001
+3.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.23%
of 13F equity value
Holder Rank
#1,275
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fragasso Financial Advisors Inc holds $24,423,418 across 9 Drug Manufacturers - General names. ABBV ranks #3 (21.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
25,026 | $6,355,853 | |
| 2 | LLY |
ELI LILLY & Co
|
4,609 | $5,528,173 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
21,001 | $5,284,691 | |
| 4 | AMGN |
Amgen Inc
|
11,714 | $4,241,873 | |
| 5 | MRK |
Merck & Co., Inc.
|
12,421 | $1,596,098 | |
| 6 | PFE |
Pfizer Inc
|
22,006 | $529,904 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,989 | $377,630 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,605 | $265,340 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,284,691 | 21,001 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $4,423,964 | 20,341 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $4,591,049 | 20,093 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $4,898,923 | 21,158 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $3,976,722 | 21,424 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $4,427,786 | 21,133 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $2,269,584 | 12,772 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $2,486,668 | 12,592 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $2,089,628 | 12,183 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $2,176,823 | 11,954 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $1,856,695 | 11,981 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $1,810,184 | 12,144 | Shares | Sole | 2023-12-06 | |
| 2023-06-30 | $1,612,044 | 11,965 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $1,863,672 | 11,694 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $1,884,695 | 11,662 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $1,561,130 | 11,632 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $1,772,980 | 11,576 | Shares | Sole | 2022-08-30 | |
| 2022-03-31 | $1,884,528 | 11,625 | Shares | Sole | 2022-04-06 | |
| 2021-12-31 | $1,553,173 | 11,471 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $1,306,305 | 12,110 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $1,291,417 | 11,465 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $1,238,253 | 11,442 | Shares | Sole | 2021-05-27 | |
| 2020-12-31 | $1,214,973 | 11,339 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $987,752 | 11,277 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $1,100,401 | 11,208 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $492,339 | 6,462 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||